WHO sets new standards for flu surveillance labs
This article was originally published in Clinica
The World Health Organization has amended the criteria for accepting confirmed cases of H5 avian flu infection, following the launch of an external quality assessment (EQA) programme aimed at "improving the global laboratory capacity for seasonal and avian influenza diagnosis".
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.